CompletedPhase 2NCT00743782
Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism
Studying Autoimmune hypoparathyroidism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Principal Investigator
- Karen K Winer, M.D., PTEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Intervention
- Synthetic Human Parathyroid Hormone 1-34 pump(drug)
- Enrollment
- 21 enrolled
- Eligibility
- 7-70 years · All sexes
- Timeline
- 2008 – 2014
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00743782 on ClinicalTrials.gov